FDA's Pazdur To Retain Drug Approval Duties In Oncology Center Of Excellence

Center for Drug Evaluation and Research's long-time director of oncology/hematology products office will continue as signatory on drug reviews even after new Cancer Moonshot-driven structure takes effect.